TY - JOUR
T1 - Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite
AU - Ito, Junitsu
AU - Ghosh, Anil
AU - Moreira, Luciano A.
AU - Wimmer, Ernst A.
AU - Jacobs-Lorena, Marcelo
N1 - Funding Information:
We thank J. Snyder and G. Hundemer for help, and members of the laboratory for comments. This investigation received financial support from the UNDP/World Bank/ WHO Special Programme for Research and Training in Tropical Diseases (TDR) and from the National Institutes of Health. E.A.W. acknowledges support by the Robert Bosch Foundation.
Funding Information:
We thank the patients for contributing to this study; Y. Terado for discussions on immunohistochemistry, K. Tachampa and J. Y. Kim for help in characterization of URAT1; A. Toki, M. Takahashi and M. Ikeda for technical assistance; and Merck Research Laboratories for providing losartan and EXP-3174. The anti-URAT1 polyclonal antibody was supplied by Trans Genic Inc. (formerly Kumamoto Immunochemical Laboratory). This work was supported in part by grants from the Japanese Ministry of Education, Science, Sports, Culture and Technology, Grants-in-Aid for Scientific Research, and High-Tech Research Center, the Science Research Promotion Fund of the Japan Private School Promotion Foundation.
PY - 2002/5/23
Y1 - 2002/5/23
N2 - Malaria is estimated to cause 0.7 to 2.7 million deaths per year, but the actual figures could be substantially higher owing to under-reporting and difficulties in diagnosis. If no new control measures are developed, the malaria death toll is projected to double in the next 20 years. Efforts to control the disease are hampered by drug resistance in the Plasmodium parasites, insecticide resistance in mosquitoes, and the lack of an effective vaccine. Because mosquitoes are obligatory vectors for malaria transmission, the spread of malaria could be curtailed by rendering them incapable of transmitting parasites. Many of the tools required for the genetic manipulation of mosquito competence for malaria transmission have been developed. Foreign genes can now be introduced into the germ line of both culicine and anopheline mosquitoes, and these transgenes can be expressed in a tissue-specific manner. Here we report on the use of such tools to generate transgenic mosquitoes that express antiparasitic genes in their midgut epithelium, thus rendering them inefficient vectors for the disease. These findings have significant implications for the development of new strategies for malaria control.
AB - Malaria is estimated to cause 0.7 to 2.7 million deaths per year, but the actual figures could be substantially higher owing to under-reporting and difficulties in diagnosis. If no new control measures are developed, the malaria death toll is projected to double in the next 20 years. Efforts to control the disease are hampered by drug resistance in the Plasmodium parasites, insecticide resistance in mosquitoes, and the lack of an effective vaccine. Because mosquitoes are obligatory vectors for malaria transmission, the spread of malaria could be curtailed by rendering them incapable of transmitting parasites. Many of the tools required for the genetic manipulation of mosquito competence for malaria transmission have been developed. Foreign genes can now be introduced into the germ line of both culicine and anopheline mosquitoes, and these transgenes can be expressed in a tissue-specific manner. Here we report on the use of such tools to generate transgenic mosquitoes that express antiparasitic genes in their midgut epithelium, thus rendering them inefficient vectors for the disease. These findings have significant implications for the development of new strategies for malaria control.
UR - http://www.scopus.com/inward/record.url?scp=0037161738&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037161738&partnerID=8YFLogxK
U2 - 10.1038/417452a
DO - 10.1038/417452a
M3 - Article
C2 - 12024215
AN - SCOPUS:0037161738
SN - 0028-0836
VL - 417
SP - 452
EP - 455
JO - Nature
JF - Nature
IS - 6887
ER -